Investors Count

2

Deal Terms

2

Funding, Valuation & Revenue

3 Fundings

Strongbridge Biopharma's latest funding round was a Acq - P2P for on October 5, 2021.

Strongbridge Biopharma's valuation in October 2015 was $212.05M.

Strongbridge Biopharma's latest post-money valuation is from October 2021.

Sign up for a free demo to see Strongbridge Biopharma's valuations in October 2021 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

10/5/2021

Acq - P2P

$XXM

0

FY undefined

6

10/16/2015

IPO

$XXM

$212.05M

0

FY undefined

10

1/1/2015

Unattributed VC

$XXM

0

FY undefined

0

Date

10/5/2021

10/16/2015

1/1/2015

Round

Acq - P2P

IPO

Unattributed VC

Amount

$XXM

Investors

Valuation

$XXM

$212.05M

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

Sources

6

10

0

Start free trial
New call-to-action

Strongbridge Biopharma Deal Terms

2 Deal Terms

Strongbridge Biopharma's deal structure is available for 2 funding rounds, including their Acq - P2P from October 05, 2021.

Round

Acq - P2P

IPO

Funding Date

$XXM

$XXM

Pre-Money Valuation

$XXM

Post-Money Valuation

$XXM

$XXM

Amount Raised

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

$XXM

Board Voting

$XXM

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acq - P2P

$XXM

$XXM

$XXM

$XXM

IPO

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Strongbridge Biopharma Investors

2 Investors

Strongbridge Biopharma has 2 investors. Xeris Pharmaceuticals invested in Strongbridge Biopharma's Acq - P2P funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/5/2021

10/5/2021

1
Acq - P2P

Corporation

Illinois

00/00/0000

00/00/0000

TVM Capital Life Science

Subscribe to see more

Venture Capital

Germany

First funding

10/5/2021

00/00/0000

Last Funding

10/5/2021

00/00/0000

Investor

TVM Capital Life Science

Rounds

1
Acq - P2P

Subscribe to see more

Board Seats

Type

Corporation

Venture Capital

Location

Illinois

Germany

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.